Politics
Novo Nordisk sues rival Eli Lilly over weight loss drug advertising
The Hill·July 21, 2026·1 min read
Novo Nordisk sued Eli Lilly on Tuesday, accusing the rival drugmaker of false advertising over weight loss drug performance. The federal lawsuit in New Jersey alleges Lilly intentionally selected outdated studies to show Mounjaro and Zepbound lead to more weight loss than Ozempic.
Read at The HillDaily crypto arcade
Read the news, then play it.
Chainshorts turns crypto headlines into a daily game. Catch up in 60 words, then jump into daily lucky draws for a shot at the pot.